Atorvastatin activates heme oxygenase-1 at the stress response elements

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 2, 2012, Pages 394-400

  Kwok, Simon C M ^a   Samuel, Solomon P ^a   Handal, John ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Antioxidant response element; Apoptosis; Atorvastatin; Heme oxygenase 1; Statin

Indexed keywords

ATORVASTATIN; GERANYLGERANYL PYROPHOSPHATE; HEME OXYGENASE 1; HEPTANOIC ACID DERIVATIVE; ISOPRENOID PHOSPHATE; PYRROLE DERIVATIVE;

APOPTOSIS; ARTICLE; BREAST TUMOR; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; OXIDATIVE STRESS; PROMOTER REGION; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HEME OXYGENASE-1; HEPTANOIC ACIDS; HUMANS; MALE; OXIDATIVE STRESS; POLYISOPRENYL PHOSPHATES; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PYRROLES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84856322114     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01324.x     Document Type: Article

References (44)

1. Pruitt K, Der CJ. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 2001; 171: 1-10.
2. Hindler K, Cleeland CS, Rivera E, et al The role of statins in cancer therapy. Oncologist. 2006; 11: 306-15.
3. Shibata MA, Kavanaugh C, Shibata E, et al Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis. 2003; 24: 453-9.
4. Mück AO, Seeger H, Wallwiener D. Inhibitory effect of statins on the proliferation of human breast cancer cells. Int J Clin Pharmacol Ther. 2004; 42: 695-700.
5. Sivaprasad U, Abbas T, Dutta A. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Mol Cancer Ther. 2006; 5: 2310-6.
6. Zheng X, Cui XX, Avila GE, et al Atorvastatin and celecoxib inhibit prostate PC-3 tumours in immunodeficient mice. Clin Cancer Res. 2007; 13: 5480-7.
7. Hoque A, Chen H, Xu XC. Statin induces apoptosis and cell growth arrest in prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 2008; 17: 88-94.
8. Sánchez CA, Rodrìguez E, Varela E, et al Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest. 2008; 26: 698-707.
9. Ghosh PM, Ghosh-Choudhury N, Moyer ML, et al Role of RhoA activation in the growth and morphology of a murine prostate tumour cell line. Oncogene. 1999; 18: 4120-30.
10. Lee SJ, Ha MJ, Lee J, et al Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem. 1998; 273: 10618-23.
11. Park C, Lee I, Kang WK. Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death. Carcinogenesis. 2001; 22: 1727-31.
12. Marcelli M, Cunningham GR, Haidacher SJ, et al Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998; 58: 76-83.
13. Shibata MA, Ito Y, Morimoto J, et al Lovastatin inhibits tumour growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis. 2004; 25: 1887-98.
14. Sekine Y, Furuya Y, Nishii M, et al Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor. Biochem Biophys Res Commun. 2008; 372: 356-61.
15. Kotamraju S, Williams CL, Kalyanaraman B. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Cancer Res. 2007; 67: 7386-94.
16. Oliveira KA, Zecchin KG, Alberici LC, et al Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction. J Bioenerg Biomembr. 2008; 40: 307-14.
17. Parikh A, Childress C, Deitrick K, et al Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells. Prostate. 2010; 70: 971-81.
18. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H: quinine oxidoreductase1 gene. Proc Natl Acad Sci USA. 1996; 93: 14960-5.
19. Sun X, Shimizu H, Yamamoto K. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol Cell Biol. 1995; 15: 4489-96.
20. Gilley J, Coffer PJ, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol. 2003; 162: 613-22.
21. Alam J, Cook JL. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des. 2003; 9: 2499-511.
22. Okinaga S, Takahashi K, Takeda K, et al Regulation of human heme oxygenase-1 gene expression under thermal stress. Blood. 1996; 87: 5074-84.
23. Kallin A, Johannessen LE, Cani PD, et al SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma. J Lipid Res. 2007; 48: 1628-36.
24. Deshane J, Kim J, Bolisetty S, et al Sp1 regulates chromatin looping between an intronic enhancer and distal promoter of the human heme oxygenase-1 gene in renal cells. J Biol Chem. 2010; 285: 16476-86.
25. Kwok SCM, Daskal I. Brefeldin A activates CHOP promoter at the AARE, ERSE and AP-1 elements. Mol Cell Biochem. 2008; 319: 203-8.
26. Gueron G, De Siervi A, Ferrando M, et al Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res. 2009; 7: 1745-55.
27. Hill M, Pereira V, Chauveau C, et al Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3-dioxygenase. FASEB J. 2005; 19: 1957-68.
28. Cafforio P, Dammacco F, Gernone A, et al Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis. 2005; 26: 883-91.
29. Fromigué O, Haÿ E, Modrowski D, et al RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ. 2006; 13: 1845-56.
30. Grosser N, Erdmann K, Hemmerle A, et al Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun. 2004; 325: 871-6.
31. Chen JC, Huang KC, Lin WW. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell Signal. 2006; 18: 32-9.
32. Hsieh CH, Rau CS, Hsieh MW, et al Simvastatin-induced heme oxygenase-1 increases apoptosis of Neuro 2A cells in response to glucose deprivation. Toxicol Sci. 2008; 101: 112-21.
33. Habeos IG, Ziros PG, Chartoumpekis D, et al Simvastatin activates Keap1/Nrf2 signaling in rat liver. J Mol Med. 2008; 86: 1279-85.
34. Min KS, Lee YM, Hong SO, et al Simvastatin promotes odontoblastic differentiation and expression of angiogenic factors via heme oxygenase-1 in primary cultured human dental pulp cells. J Endod. 2010; 36: 447-52.
35. Lee TS, Chang CC, Zhu Y, et al Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation. 2004; 110: 1296-302.
36. Alam J, Cook JL. How many transcription factors does it take to turn on the heme oxygenase-1 gene? Am J Respir Cell Mol Biol. 2007; 36: 166-74.
37. Makabe S, Takahashi Y, Watanabe H, et al Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway. Atherosclerosis. 2010; 213: 377-84.
38. Reichard JF, Motz GT, Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res. 2007; 35: 7074-86.
39. Hinkelmann U, Grosser N, Erdmann K, et al Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human endothelial cells. Eur J Pharm Sci. 2010; 41: 118-24.
40. Fang J, Akaike T, Maeda H. Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis. 2004; 9: 27-35.
41. Alaoui-Jamali MA, Bismar TA, Gupta A, et al A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res. 2009; 69: 8017-24.
42. Lee YM, Jeong GS, Lim HD, et al Isoliquiritigenin 2′-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicol In Vitro. 2010; 24: 776-82.
43. Sacca P, Meiss R, Casas G, et al Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer. 2007; 97: 1683-9.
44. Lin Q, Weis S, Yang G, et al Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem. 2007; 282: 20621-33.